Medtronic, medical devices, medical technology, coronary artery disease, heart disease, syncope, pacemakers, ICD's, arrhythmia, cardiac arrest, heart failure, heart attack, cardiomyopathy, defibrillator, automated external defibrillators AEDs, heart valve, aortic aneurysms, vascular, neurological disorders, neurostimulation, shaking, Parkinson's, spinal surgery, spinal disorders, Dystonia, pain management, chronic pain, diabetes, Glucose, insulin, blood sugar, obesity, ENT, gastric, gastrointestinal, digestive problems, bladder control, incontinence, prostate, Benign Prostatic Hyperplasia

Intrathecal Drug Delivery with SynchroMed®

Intrathecal Drug Delivery with SynchroMed®
A viable alternative to oral opioids, IDD has proven efficacy in intractable nociceptive pain
patients where other therapies have failed, e.g. when oral analgesics have not been effective
or cause intolerable side-effects

Trial before implantation
Trial screening period allows patients to experience treatment and evaluate effectiveness,
before implantation

Patient satisfaction
Patient-controlled analgesia allows patients to feel more in control of the management
of their condition (within physician prescribed parameters)

Optimal dosing
Programmability allows optimal dose titration post-implant and non-invasive adjustable
dosing to meet changing patient needs

Pain Management

Pain Management